AKARI THERAPEUTICS PLC-ADR (AKTX) Stock Cash Flow
NASDAQ:AKTX - US00972G2075 - ADR
0.8187 USD
+0.09 (+12.15%)
0.7702 USD
-0.05 (-5.92%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -12.27M | -19.79M | -10.01M | -17.75M | -17.42M | |||
| Depreciation Amortization | 1.00K | 14.00K | 4.00K | 0.00 | 0.00 | |||
| Change In Working Capital | 3.04M | 6.54M | -866.00K | 820.00K | -1.98M | |||
| Interest Paid | N/A | 143.00K | N/A | N/A | N/A | |||
| Other non cash items | 206.00K | 686.00K | -5.56M | -4.58M | 560.00K | |||
| OPERATING CASH FLOW | -9.02M | -12.55M | -16.43M | -21.50M | -18.85M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| Other Investing Activity | N/A | 382.00K | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | 382.00K | N/A | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.21M | 250.00K | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 9.26M | 11.84M | 7.02M | 25.29M | 14.29M | |||
| Other Financing Activity | -832.00K | -1.10M | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 7.22M | 10.99M | 7.02M | 25.29M | 14.29M | |||
| Exchange Rate Effect | 7.00K | -4.00K | 7.00K | 110.00K | -140.00K | |||
| CHANGE IN CASH | -1.41M | -1.19M | -9.40M | 3.89M | -4.69M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -9.02M | -12.55M | -16.43M | -21.50M | -18.85M | |||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| FREE CASH FLOW | -9.02M | -12.55M | -16.43M | -21.50M | -18.85M | |||
All data in USD